Date published: 2026-5-8

1-800-457-3801

SCBT Portrait Logo
Seach Input

Med10 Inhibitors

Med10 Inhibitors encompasses a group of compounds that exhibit a unique capacity to intricately interact with and selectively modulate the activity of the MED10 subunit within the Mediator complex. The Mediator complex, a fundamental nexus in transcriptional regulation, orchestrates the communication between transcription factors and RNA polymerase II, thereby orchestrating the finely tuned process of gene expression. Med10 Inhibitors, through their specialized molecular architecture, are adept at disrupting the orchestrated interplay centered around MED10, a pivotal mediator that bridges the gap between transcriptional activators and the RNA polymerase transcription machinery. These inhibitors operate by enacting a deliberate influence on cellular processes, culminating in a cascade of events that reverberates across the transcriptional landscape. By engaging MED10 or its intricate molecular companions, these inhibitors induce perturbations in the delicate equilibrium of the transcriptional machinery, leading to nuanced shifts in the dynamics of gene transcription. It is within the realm of this chemical class that researchers are actively probing the molecular nuances to decipher the multifaceted mechanisms through which they exact their influence. The Med10 Inhibitor category boasts a diverse array of structural motifs, each bestowing a unique set of properties that enables them to interface with MED10 and its collaborating entities in distinct ways. The evolving understanding of these inhibitors encompass an intricate tapestry of interactions that holds promise for unraveling fundamental biological intricacies. Despite this burgeoning comprehension, it is imperative to acknowledge that the Med10 Inhibitor realm remains a subject of relentless scientific scrutiny. The specificities of their chemical scaffolds, their detailed modes of interaction with MED10 and its fellow constituents, and the potential downstream effects on transcriptional processes are all focal points of ongoing investigation. This chemical class holds the potential to uncover hitherto uncharted territories within the realm of transcriptional regulation, unveiling novel insights into the orchestration of genetic information transfer.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

THZ1

1604810-83-4sc-507542
1 mg
$95.00
(0)

THZ1 is a covalent inhibitor of Cdk7, a kinase subunit of the CDK-activating kinase (CAK) complex within Mediator.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

Originally developed as a cyclin-dependent kinase inhibitor, it also targets CDK8 and CDK19 within the Mediator complex.